| 标题 |
Efficacy and safety of second-line treatments in patients with advanced EGFR-mutated non-small cell lung cancer progressing on osimertinib without identified targetable resistance mechanism at progression |
| 网址 | |
| DOI | |
| 其它 |
期刊:Respiratory medicine and research 作者:Lajoinie P; Fallet V; Wislez M; du Rusquec P; Gounant V; et al 出版日期:2026/05/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)